Valuation: QHSLab, Inc.

Market Cap 39.84L 34.83L 32L 29.83L 56.58L 38Cr 57.44L 3.84Cr 1.49Cr 19Cr 1.5Cr 1.46Cr 64Cr P/E 2024
-8.27x
P/E 2025 30.3x
Enterprise Value 36.4L 31.82L 29.25L 27.26L 51.71L 35Cr 52.49L 3.51Cr 1.36Cr 17Cr 1.37Cr 1.34Cr 59Cr EV / Sales 2024
1.97x
EV / Sales 2025 2.41x
Free-Float
51.27%
Yield 2024 *
-
Yield 2025 -
1 day-11.67%
1 month-41.18%
3 months-60.74%
6 months-70.55%
Current year-56.26%
1 month 0.25
Extreme 0.2457
0.43
Current year 0.25
Extreme 0.2457
1.14
1 year 0.08
Extreme 0.08
1.14
3 years 0.02
Extreme 0.0155
1.14
5 years 0.02
Extreme 0.0155
1.14
10 years 0
Extreme 0.005
1.14
Manager TitleAgeSince
Chief Executive Officer 49 28/06/2016
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 02/05/2024
Director TitleAgeSince
Chairman 49 28/06/2016
Date Insider Type Main position Quantity % Market Cap.
31/12Conversion

Chief Executive Officer

2,13,075 1.8887%
31/12Others

Chief Executive Officer

26,44,424 100.0000%
31/12Others

Chief Executive Officer

10,80,092 100.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-11.67%-.--%+26.19%+79.05% 39.84L
+1.97%+2.03%+21.92%+0.83% 19TCr
+5.87%+5.27%-21.76%+26.78% 15TCr
+2.17%+0.89%-2.59%-16.42% 14TCr
+4.83%+2.06%-56.73%-15.69% 6.71TCr
+2.59%+3.95%+22.89%+3.15% 5.43TCr
+0.03%+2.19%-25.48%-31.00% 4.46TCr
-2.02%-3.91%+7.67%+9.53% 3.69TCr
+0.31%+1.30%+8.30%+43.25% 3.72TCr
+1.09%-0.30%-13.81%-18.74% 2.98TCr
Average +0.52%-0.18%-3.34%+8.07% 7.56TCr
Weighted average by Cap. +2.66%+3.26%-3.84%+1.38%

Financials

2024 2025
Net sales 21.32L 18.64L 17.13L 15.96L 30.28L 20Cr 30.74L 2.06Cr 79.93L 9.98Cr 80.02L 78.31L 34Cr 26.92L 23.53L 21.63L 20.16L 38.23L 26Cr 38.81L 2.6Cr 1.01Cr 13Cr 1.01Cr 98.87L 43Cr
Net income -3L -2L -2L -2L -4L -2.47Cr -4L -25L -10L -1.21Cr -10L -10L -4.18Cr 5L 4L 4L 3L 6L 4.36Cr 7L 44.12L 17.15L 2.14Cr 17.17L 16.8L 7.38Cr
Net Debt 15.79L 13.8L 12.68L 11.82L 22.42L 15Cr 22.76L 1.52Cr 59.19L 7.39Cr 59.26L 57.99L 25Cr -3L -3L -3L -3L -5L -3.27Cr -5L -33.11L -12.87L -1.61Cr -12.89L -12.61L -5.54Cr
Logo QHSLab, Inc.
QHSLab, Inc. is a medical device technology and software as a service (SaaS) company focused on primary care physicians (PCPs) and other healthcare providers to offer tools to evaluate and treat chronic diseases as well as provide preventive care through reimbursable procedures. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. It also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians.
Employees
12
Date Price Change Volume
25/26/25 $0.2650 -11.67% 27,147
  1. Stock Market
  2. Stocks
  3. USAQ Stock